CYTOKINE MARKET ANALYSIS

Regional Analysis

Global Cytokine Market: Regional Insights

Based on geography, the cytokine market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period due to the rising prevalence of cancer (especially in the United States) and increasing acceptance in cancer therapy in this region. For instance, to date, two cytokines have achieved FDA (the U.S. Food and Drug Administration) approval as single agents for cancer treatment: high-dose, bolus IL-2 for metastatic melanoma and renal cell carcinoma and IFN-α for the adjuvant therapy of Stage III melanoma.

Asia Pacific is also expected to witness robust growth in the global cytokine market due to the increase in prevalence of chronic disease, such as cancer, or increase in burden of cancer. For instance, in cancer, cytokine therapy help the immune system kill cancer cells or keep them from growing. According to the report by the Indian Council of Medical Research (ICMR) on the ‘Burden of cancers in India’, the number of Indians suffering from cancer is expected to increase to 29.8 million in 2025 from 26.7 million in 2021.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa